Sponsored by
This is impressive. After a single injection, they had a complete response to a recurrent gbm, and 20% of the patients did much better than expected - although unfortunately they all died. This is a step forward - it has to be fined tuned: optimize the delivery and schedule of it and see which drugs can make it work better.